Atropopeptides are a Novel Family of Ribosomally Synthesized and Posttranslationally Modified Peptides with a Complex Molecular Shape

• DOI: 10.1002/ange.202208361
• Publication Date: 2022-08-08T15:23:35Z
• Authors: Pakjira Nanudorn; Sirinthra Thiengmag; Friederike Biermann; Pelin Erkoc; Sabrina D. Dirnbe...; Thao N. Phan; Robert Fürst; Reiko Ueoka; Eric J. N. Helfrich
• Keywords: Biological Products; Nitrogen; Multigene Family; Peptides; Protein Processing, Post-Translational; Ribosomes; 01 natural sciences; Communications; Carbon; Mixed Function Oxygenases; 0104 chemical sciences

AbstractBiomacromolecules are known to feature complex three‐dimensional shapes that are essential for their function. Among natural products, ambiguous molecular shapes are a rare phenomenon. The hexapeptide tryptorubin A can adopt one of two unusual atropisomeric configurations. Initially hypothesized to be a non‐ribosomal peptide, we show that tryptorubin A is the first characterized member of a new family of ribosomally synthesized and posttranslationally modified peptides (RiPPs) that we named atropopeptides. The sole modifying enzyme encoded in the gene cluster, a cytochrome P450 monooxygenase, is responsible for the atropospecific formation of one carbon‐carbon and two carbon‐nitrogen bonds. The characterization of two additional atropopeptide biosynthetic pathways revealed a two‐step maturation process. Atropopeptides promote pro‐angiogenic cell functions as indicated by an increase in endothelial cell proliferation and undirected migration. Our study expands the biochemical space of RiPP‐modifying enzymes and paves the way towards the chemoenzymatic utilization of atropopeptide‐modifying P450s.